Skip to main content
Log in

Six weeks phylloquinone supplementation produces undesirable effects on blood lipids with no changes in inflammatory and fibrinolytic markers in postmenopausal women

  • ORIGINAL CONTRIBUTION
  • Published:
European Journal of Nutrition Aims and scope Submit manuscript

Abstract

Background

Cardiovascular disease is the major cause of death in the Western world, but some recent studies indicate that vitamin K may play a role in atherosclerosis protection.

Aim of study

The aim of this study was to evaluate the effect of phylloquinone supplementation on blood lipids, inflammatory markers and fibrinolytic activity in postmenopausal women.

Methods

Thirty-one postmenopausal women completed this placebo-controlled, randomized crossover study and received 500 µg phylloquinone or placebo in addition to their habitual diet during two periods of 6 weeks’ duration. Blood concentration of lipids, inflammatory markers and fibrinolytic parameters were measured after each period.

Results

Inflammatory markers, fibrinolytic parameters, total cholesterol and LDL-C were unaffected by the supplementation, whereas a 15% increase was seen in triacylglycerols (P = 0.015) and a 5% decrease in HDL-C (P = 0.06).

Conclusions

Six weeks supplementation with a dose of phylloquinone similar to that obtainable from the diet induced a deterioration of the lipid profile with no improvement in any of the other risk markers analysed. Thus, these results do not support a cardioprotective effect of vitamin K as has been suggested by others.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Booth SL, Martini L, Peterson JW, Saltzman E, Dallal GE, Wood RJ (2003) Dietary phylloquinone depletion and repletion in older women. J Nutr 133: 2565–2569

    CAS  Google Scholar 

  2. Braam L, Hoeks APG, Brouns F, Hamulyak K, Gerichhausen MJW, Vermeer C (2004) Beneficial effects of vitamins D and K in the elastic properties of the vessel wall in postmenopausal women: a follow-up study. Thromb Haemost 91:373–380

    CAS  Google Scholar 

  3. Bugel S, Sorensen AD, Hels O, Kristensen M, Vermeer C, Jakobsen J, Flynn A, Molgaard C, Cashman KD (2007) Effect of phylloquinone supplementation on biochemical markers of vitamin K status and bone turnover in postmenopausal women. Br J Nutr 97:373–380

    Article  CAS  Google Scholar 

  4. Eichbaum FW, Slemer O, Zyngier SB (1979) Anti-inflammatory effct of warfarin and vitamin k1. Naunyn Schmiedebergs Arch Pharmacol 307:185–190

    Article  CAS  Google Scholar 

  5. Geleijnse JM, Vermeer C, Schurgers LJ, Grobbee HAP, Witteman, Jacqueline CM (2001) Inverse association of dietary vitamin K2 intake with cardiac events and aortic atherosclerosis: the Rotterdam study. J Thromb Haemost Suppl. Ref type: abstract

  6. Geleijnse JM, Vermeer C, Grobbee DE, Schurgers LJ, Knapen MHJ, van der Meer IM, Hofman A, Witteman JCM (2004) Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam study. J Nutr 134:3100–3105

    CAS  Google Scholar 

  7. Harris TB, Ferrucci L, Tracy RP, Corti MC, Wacholder S, Ettinger WH Jr, Heimovitz H, Cohen HJ, Wallace R (1999) Associations of elevated Interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 106:506–512

    Article  CAS  Google Scholar 

  8. Hokanson JE, Austin MA (1996) Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 3:213–219

    Article  CAS  Google Scholar 

  9. Jono S, Ikari Y, Vermeer C, Dissel P, Hasegawa K, Shioi A, Taniwaki H, Kizu A, Nishizawa Y, Saito S (2004) Matrix Gla protein is associated with coronary artery calcification as assessed by electron-beam computed tomography. Thromb Heamost 91:790–794

    CAS  Google Scholar 

  10. Kawashima H, Nakajima Y, Matubara Y, Nakanowatari J, Fukata T, Mizuno S, Tkahashi S, Tajima T, Nakamura T (1997) Effects of vitamin K2 (menatetrenone) on atherosclerosis and blood coagulation in hypercholesterolemic rabbits. Jpn J Pharmacol 75:135–143

    Article  CAS  Google Scholar 

  11. Nagasawa Y, Fujii M, Kajimoto Y, Imai E, Hori M (1998) Vitamin K2 and serum cholesterol in patients on continuous ambulatory peritoneal dialysis. Lancet 351:724

    Article  CAS  Google Scholar 

  12. Reddi K, Henderson B, Meghji S, Wilson M, Poole S, Hopper C, Harris M, Hodges SJ (1995) Interleukin 6 production by lipopolysaccharide-stimulated human fibroblasts is potently inhibited by Naphthoquinone (vitamin K) compounds. Cytokine 7:287–290

    Article  CAS  Google Scholar 

  13. Ridker PM, Hennekens CH, Buring JE, Rifai N (2000) C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342:836–843

    Article  CAS  Google Scholar 

  14. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH (2000) Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101:1767–1772

    CAS  Google Scholar 

  15. Seyama Y, Hayashi M, Takegami H, Usami E (1999) Comparative effects of vitamin K2 and vitamin E on experimental atheriosclerosis. Int J Vit Nutr Res 69:23–26

    Article  CAS  Google Scholar 

  16. Shea MK, Booth SL, Massaro JM, Jacques PF, D’Agostino RB Sr, wson-Hughes B, Ordovas JM, O’Donnell CJ, Kathiresan S, Keaney JF Jr, Vasan RS, Benjamin EJ (2008) Vitamin K and vitamin D status: associations with inflammatory markers in the Framingham offspring study. Am J Epidemiol 167:313–320

    Article  Google Scholar 

  17. Spronk HMH, Soute BAM, Schurgers LJ, Thijssen HHW, De Mey JGR, Vermeer C (2003) Tissue-specific utilization of menaquinone-4 results in the prevention of arterial calcification in warfarin-treated rats. J Vasc Res 40:531–537

    Article  CAS  Google Scholar 

  18. Villines TC, Hatzigeorgiou C, Feuerstein IM, O’Malley PG, Taylor AJ (2005) Vitamin K1 intake and coronary calcification. Coron Artery Dis 16:199–203

    Article  Google Scholar 

  19. Willerson JT, Ridker PM (2004) Inflammation as a cardiovascular risk factor. Circulation 109:II-2–II-10

    Article  Google Scholar 

Download references

Acknowledgments

Financed by the European Commission Quality of Life Fifth Framework Program QLK1-1999-00752 “Optimal Nutrition towards Osteoporosis Prevention: Impact of Diet and Gene-Nutrient Interactions on Calcium and Bone Metabolism”. It does not necessarily reflect its views and in no way anticipate the Commission’s future policy in this area. The technical assistance of Hanne L Petersen and Leif S Jakobsen is gratefully acknowledged.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mette Kristensen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kristensen, M., Kudsk, J. & Bügel, S. Six weeks phylloquinone supplementation produces undesirable effects on blood lipids with no changes in inflammatory and fibrinolytic markers in postmenopausal women. Eur J Nutr 47, 375–379 (2008). https://doi.org/10.1007/s00394-008-0737-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00394-008-0737-4

Keywords

Navigation